{{ $ActivityName }}
Referred from Uro-onco/Urologist
Referred from Surgical/Radiation oncologist
Direct patient
Metastatic castration sensitive (mCSPC/mHSPC)
Non-metastatic castration resistant (nmCRPC)
Metastatic castration resistant (mCRPC)
1L mCSPC/mHSPC
2L mCSPC/mHSPC
ADT+ Abiraterone + Prednisolone
ADT+ Enzalutamide
ADT+ Docetaxel
ADT+ Docetaxel + Darolutamide or Abiraterone
ADT only
240 MG DAILY
180 MG DAILY
120 MG DAILY
60 MG DAILY
Surgical Castration
Medical Castration (LhRh agonist/Antagonist)
LhRh agonist (Luprolide/Gosereline/Triptoreline)
LhRh antagonist (Degarelix/Relugolix)
Yes
No
Not assessed
Complete response
Partial response
Stable disease
Cash
Govt reimbursed
Insurance
State Yojna/ Ayushman Bharat Scheme